Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 19 studies | 73% ± 15% | |
endothelial cell | 19 studies | 34% ± 16% | |
oligodendrocyte precursor cell | 16 studies | 70% ± 21% | |
oligodendrocyte | 14 studies | 37% ± 18% | |
microglial cell | 14 studies | 44% ± 16% | |
glutamatergic neuron | 13 studies | 67% ± 19% | |
fibroblast | 12 studies | 36% ± 12% | |
GABAergic neuron | 11 studies | 69% ± 24% | |
smooth muscle cell | 11 studies | 40% ± 11% | |
ciliated cell | 10 studies | 35% ± 17% | |
macrophage | 10 studies | 38% ± 18% | |
adipocyte | 10 studies | 37% ± 14% | |
type I pneumocyte | 9 studies | 49% ± 24% | |
neuron | 7 studies | 53% ± 23% | |
epithelial cell | 7 studies | 36% ± 14% | |
interneuron | 7 studies | 60% ± 29% | |
club cell | 6 studies | 42% ± 19% | |
pericyte | 5 studies | 33% ± 15% | |
cardiac muscle cell | 5 studies | 44% ± 11% | |
endothelial cell of lymphatic vessel | 5 studies | 25% ± 8% | |
type II pneumocyte | 5 studies | 40% ± 9% | |
cholangiocyte | 4 studies | 40% ± 24% | |
hepatocyte | 4 studies | 61% ± 27% | |
granule cell | 4 studies | 64% ± 11% | |
mesothelial cell | 4 studies | 34% ± 8% | |
Mueller cell | 4 studies | 85% ± 12% | |
retinal ganglion cell | 4 studies | 66% ± 21% | |
basal cell | 4 studies | 33% ± 7% | |
myeloid cell | 4 studies | 29% ± 9% | |
respiratory goblet cell | 4 studies | 35% ± 12% | |
ionocyte | 3 studies | 24% ± 4% | |
hepatic stellate cell | 3 studies | 40% ± 14% | |
differentiation-committed oligodendrocyte precursor | 3 studies | 66% ± 8% | |
GABAergic interneuron | 3 studies | 73% ± 15% | |
vein endothelial cell | 3 studies | 30% ± 20% | |
GABAergic amacrine cell | 3 studies | 45% ± 12% | |
retina horizontal cell | 3 studies | 52% ± 22% | |
endothelial cell of vascular tree | 3 studies | 35% ± 23% | |
abnormal cell | 3 studies | 29% ± 10% | |
neural progenitor cell | 3 studies | 35% ± 12% | |
ependymal cell | 3 studies | 76% ± 7% | |
myofibroblast cell | 3 studies | 34% ± 13% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 30% ± 7% | |
kidney loop of Henle epithelial cell | 3 studies | 36% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 97% | 4993.09 | 1755 / 1809 | 96% | 31.63 | 454 / 472 |
brain | 94% | 2691.81 | 2485 / 2642 | 98% | 21.84 | 690 / 705 |
esophagus | 100% | 4560.88 | 1440 / 1445 | 92% | 15.90 | 168 / 183 |
thymus | 100% | 6374.75 | 653 / 653 | 89% | 31.16 | 537 / 605 |
lung | 99% | 4325.44 | 573 / 578 | 87% | 14.83 | 1008 / 1155 |
pancreas | 97% | 1909.40 | 317 / 328 | 80% | 6.70 | 143 / 178 |
uterus | 96% | 2740.21 | 164 / 170 | 78% | 11.41 | 358 / 459 |
intestine | 94% | 5152.90 | 906 / 966 | 77% | 6.42 | 405 / 527 |
breast | 99% | 4898.17 | 455 / 459 | 71% | 9.49 | 791 / 1118 |
kidney | 97% | 2590.06 | 86 / 89 | 64% | 5.71 | 581 / 901 |
liver | 98% | 3715.59 | 222 / 226 | 61% | 6.53 | 248 / 406 |
stomach | 84% | 2975.64 | 300 / 359 | 73% | 8.00 | 208 / 286 |
bladder | 81% | 2805.43 | 17 / 21 | 63% | 6.39 | 316 / 504 |
ovary | 62% | 1177.48 | 112 / 180 | 73% | 7.31 | 314 / 430 |
prostate | 97% | 3233.64 | 237 / 245 | 23% | 1.42 | 115 / 502 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.71 | 1 / 1 |
blood vessel | 100% | 11025.73 | 1334 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 28.54 | 79 / 80 |
adipose | 96% | 2889.64 | 1156 / 1204 | 0% | 0 | 0 / 0 |
heart | 87% | 2114.04 | 749 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 13.06 | 37 / 45 |
adrenal gland | 30% | 369.05 | 78 / 258 | 39% | 3.56 | 89 / 230 |
muscle | 23% | 315.02 | 186 / 803 | 0% | 0 | 0 / 0 |
spleen | 7% | 98.13 | 18 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.15 | 1 / 29 |
peripheral blood | 1% | 16.71 | 13 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032508 | Biological process | DNA duplex unwinding |
GO_0007605 | Biological process | sensory perception of sound |
GO_0003025 | Biological process | regulation of systemic arterial blood pressure by baroreceptor feedback |
GO_0022008 | Biological process | neurogenesis |
GO_0007608 | Biological process | sensory perception of smell |
GO_0021563 | Biological process | glossopharyngeal nerve development |
GO_0007399 | Biological process | nervous system development |
GO_0007626 | Biological process | locomotory behavior |
GO_0021564 | Biological process | vagus nerve development |
GO_0021554 | Biological process | optic nerve development |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005614 | Cellular component | interstitial matrix |
GO_0008201 | Molecular function | heparin binding |
GO_0005515 | Molecular function | protein binding |
GO_0043138 | Molecular function | 3'-5' DNA helicase activity |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | NAV2 |
Protein name | NAV2 protein Neuron navigator 2 (EC 3.6.4.12) (Helicase APC down-regulated 1) (Pore membrane and/or filament-interacting-like protein 2) (Retinoic acid inducible in neuroblastoma 1) (Steerin-2) (Unc-53 homolog 2) (unc53H2) Neuron navigator 2 Neuroblastoma neuron navigator 2 |
Synonyms | HELAD1 RAINB1 STEERIN2 POMFIL2 KIAA1419 |
Description | FUNCTION: Possesses 3' to 5' helicase activity and exonuclease activity. Involved in neuronal development, specifically in the development of different sensory organs. . |
Accessions | ENST00000396085.6 [Q8IVL1-2] ENST00000650578.1 A0A3B3ISY2 E9PLU3 ENST00000349880.9 [Q8IVL1-3] ENST00000360655.8 [Q8IVL1-4] ENST00000533917.5 [Q8IVL1-5] Q8IVL1 ENST00000396087.7 [Q8IVL1-1] A7E2D6 ENST00000525322.5 ENST00000530408.1 E9PNV5 B7SSU1 |